Dr. Hiten D Madhani's lab focuses on understanding the genetic factors that influence the behaviour and evolution of the fungal pathogen Cryptococcus neoformans, the leading cause of fungal meningitis. They explore how different genetic backgrounds affect the pathogen's ability to infect hosts and respond to treatments. By generating genomic resources and employing cutting-edge techniques like CRISPR, the lab aims to provide critical insights that could help develop new therapies for treating invasive fungal infections.

Dr. Danica Galonic Fujimori's lab focuses on understanding how certain bacteria develop resistance to antibiotics through modifications to their ribosomes. This research is important because it helps us combat the growing problem of antibiotic resistance, which affects public health and treatment options. The lab uses advanced techniques to study the enzymes involved in this process and aims to uncover new strategies to tackle bacterial infections.

Dr. Yin Shen's lab at UCSF focuses on understanding the genetic factors that contribute to Alzheimer's disease, specifically how risk genes and their variants influence gene expression and related biological functions. The lab uses advanced techniques such as CRISPR and single-cell analysis to study the interactions between these genetic factors and the disease. By examining nerve cells and brain organoids, the lab aims to uncover new insights that could lead to better risk predictions and therapeutic targets for Alzheimer's disease.

Dr. Kathleen Giacomini's lab at UCSF focuses on studying membrane transporters, which are crucial for moving drugs, nutrients, and other substances across cell membranes, especially in the brain. The lab seeks to understand how these transporters work in the blood-brain barrier, a critical site that regulates what enters the brain. By using cutting-edge methods like structural biology and computational modeling, the team aims to identify potential new treatments and improve our understanding of drug delivery in the brain.

Dr. Peter Turnbaugh's lab focuses on understanding how the gut microbiome influences the metabolism of cancer drugs, particularly fluoropyrimidines used in colorectal cancer treatment. By examining the interactions between gut bacteria and these drugs, the research aims to reveal why there are differences in drug effectiveness and side effects among patients. This work could lead to better treatment strategies that take into account individual differences in gut microbiota.

Dr. Corey C. Harwell's lab focuses on understanding the development and function of specific neurons in the septal complex of the brain, which plays a key role in social behavior and emotional regulation. The lab investigates how early life exposure to opioids can lead to long-term changes in brain function and contribute to neuropsychiatric disorders. By analyzing the molecular pathways and cellular adaptations in these neurons, the research aims to uncover potential therapeutic targets for treating conditions like anxiety and depression.

Dr. Stephen L. Hauser's lab at UCSF focuses on understanding the role of B cells in multiple sclerosis (MS), a debilitating autoimmune disease of the central nervous system. The team investigates how B cells contribute to the onset and progression of MS by studying samples from patients at different stages of the disease. They combine advanced imaging techniques, genetic analysis, and innovative antibody technologies to uncover the mechanisms that trigger MS and influence its progression, aiming to improve therapeutic strategies for patients.

Dr. Ryan D. Hernandez's lab focuses on human genetics and evolution, particularly how genetic ancestry affects complex traits across diverse populations. The lab utilizes an extensive dataset from the Trans-Omics for Precision Medicine project to investigate genetic variations and their implications for human health. Their research integrates evolutionary theory with modern computational methods to address pressing questions related to health disparities and precision medicine.

James Holton's lab focuses on structural biology, particularly understanding how the structures of macromolecules relate to their functions. They develop new methods and tools for accurate molecular modeling and data collection to bridge the gap between predicted and real structures of biological molecules. By improving the resolution and accuracy of imaging techniques, the lab aims to unlock deeper insights into essential biological processes and drug design.

Dr. Graeme W. Davis's lab at UCSF studies homeostatic plasticity, which helps neurons stabilize their function in response to changes. Their research focuses on the mechanisms linking this plasticity to neurodevelopmental disorders, mental health, and age-related declines in neuromuscular function. By investigating these connections, the lab aims to explore new therapeutic strategies for conditions like Jordan's Syndrome and other neurodegenerative diseases.

Dr. Matthew Krummel's lab at UCSF focuses on understanding how the immune system distinguishes between self and foreign cells. Through innovative research on immune cells like T cells and dendritic cells, the lab aims to improve treatments for cancer and autoimmune diseases. They explore specific cellular mechanisms that could enhance the effectiveness of immunotherapies, ultimately aiming to boost the body's ability to fight tumors while minimizing autoimmunity.

Dr. Ari B. Molofsky's lab at UCSF focuses on understanding the immune system's responses to allergens and brain injuries. The research primarily investigates how certain immune cells, called type 2 lymphocytes, function and localize within tissues during inflammation. The lab also explores the role of fibroblast cells in the brain and how they interact with the immune system to influence recovery from injury. The findings aim to inform future therapies for allergic diseases and neuroinflammatory conditions.

Aimee Kao's research lab focuses on understanding the role of lysosomes in neurodegenerative diseases such as Alzheimer's and frontotemporal dementia. The lab studies how specific protein fragments, known as PGRN species, influence the degradation of a harmful protein called TDP-43, especially as people age. By exploring these mechanisms, the lab aims to identify potential new treatments for these age-related disorders.

Dr. Galateia J Kazakia's research lab focuses on understanding bone health in patients with chronic kidney disease (CKD) and those recovering from fractures. The lab is exploring innovative, non-invasive methods to assess bone turnover, which is critical for managing fracture risk. By using advanced imaging techniques, the lab aims to improve patient care and develop strategies to prevent fractures, especially in older patients.

Dr. Joel H. Kramer and his lab at UCSF focus on understanding small vessel cerebrovascular disease, particularly how it contributes to cognitive decline in older adults. They aim to identify reliable markers that can help detect and monitor this disease early on, improving how we diagnose and treat affected patients. By following a diverse group of older individuals showing signs of cerebrovascular issues, they are working to validate new neuroimaging and fluid-based biomarkers that could greatly enhance clinical trials and patient care.

Dr. Hyunil Jo's lab at UCSF focuses on researching liver fibrosis, a severe condition that leads to liver failure. The lab is working on developing new drugs that target an enzyme called acid ceramidase, which has been shown to play a significant role in liver fibrosis. By creating potent inhibitors of this enzyme, they hope to provide effective treatments for patients suffering from chronic liver diseases, where current options are limited.

Dr. Stephen L. Nishimura's lab at UCSF focuses on understanding how the transforming growth factor-beta (TGF-β) cytokine regulates fibrosis and inflammation in the lungs. Their research aims to uncover the molecular mechanisms of TGF-β activation to develop more targeted and effective therapies for lung diseases like pulmonary fibrosis, which currently have few treatment options.

Dr. Aashish Manglik's lab at UCSF focuses on understanding how our sense of smell works. They study specific proteins called odorant receptors, which allow us to detect various smells. By analyzing the structure and function of these receptors, the lab aims to uncover the mechanisms of smell perception, which could lead to new treatments for smell-related disorders.

Dr. Kaveh Ashrafi's lab at UCSF focuses on understanding how metabolism influences learning and memory, particularly during aging. They study the kynurenine pathway and the role of a steroid hormone called ADIOL, aiming to uncover mechanisms that could improve cognitive function in the context of neurodegenerative diseases like Alzheimer's. By using model organisms like C. elegans, the lab explores how changes in metabolic pathways affect brain health and learning capabilities.

Dr. Bruce L. Miller's research lab at UCSF focuses on understanding and addressing dementia in Latino populations, a group that has been historically underrepresented in dementia research. Through a multi-partner consortium, the lab investigates the effects of socioeconomic factors, genetic variants, and brain aging on Alzheimer's disease and frontotemporal lobar degeneration. By gathering data from participants across Latin America and the United States, the lab aims to develop culturally tailored interventions to improve dementia care and outcomes.